Stifel Financial’s Pulse Biosciences PLSE Stock Holding History

Stifel Financial’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,190	Closed	-$349K	–	2631
2017 Q2	$349K	Buy	+10,190	New	+$280K	﹤0.01%	2055

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Stifel Financial's PLSE Position: Q3 2017 in Review

Stifel Financial sold out of Pulse Biosciences (PLSE) in Q3 2017, closing a stake of 10,190 shares — an estimated $349K sold.

Stifel Financial first reported a position in PLSE in Q2 2017 and held it in 1 quarter. The position peaked at $349K in Q2 2017. 43 funds tracked by Wall St. Rank hold PLSE as of Q3 2017.

Stifel Financial reported no remaining Pulse Biosciences position as of Q3 2017 after selling out during the quarter.
Stifel Financial sold 10,190 Pulse Biosciences shares in Q3 2017, an estimated $349K.
Stifel Financial first reported a position in Pulse Biosciences in Q2 2017 and held it in 1 quarter.
Stifel Financial's Pulse Biosciences position peaked at $349K in Q2 2017.
43 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2017.

Based on Stifel Financial's 13F filing for Q3 2017, filed 13 Nov 2017.